Side-by-side comparison of AI visibility scores, market position, and capabilities
Largest independent E&P with 2M BOE/day; $22.5B Marathon Oil acquisition 2024; $40/bbl breakeven portfolio; LNG optionality through APLNG and Port Arthur; NYSE: COP.
ConocoPhillips is one of the world's largest independent exploration and production companies, tracing its roots to Continental Oil Company (Conoco) founded in 1875 and Phillips Petroleum founded in 1905, merging to form ConocoPhillips in 2002. Headquartered in Houston, Texas and trading on NYSE (COP), the company generated approximately $55.2 billion in total revenues for FY2024 and produces roughly 2.0 million barrels of oil equivalent per day across its diversified global portfolio. Under CEO Ryan Lance, ConocoPhillips completed the transformational acquisition of Marathon Oil in November 2024 for approximately $22.5 billion, adding significant Permian Basin, Eagle Ford, and Bakken acreage and reinforcing COP's position as the dominant large-cap independent E&P.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.